Center for Neuromodulation in Depression and Stress, University of Pennsylvania — Philadelphia, Pennsylvania

Center for Neuromodulation in Depression and Stress, University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Center for Neuromodulation in Depression and Stress, University of Pennsylvania has participated in 1 clinical trials.

Therapeutic areas: Bipolar Depression, Treatment Resistant Depression.

Sponsors: University of Pennsylvania.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Neuromodulation in Depression and Stress, University of Pennsylvania?

Center for Neuromodulation in Depression and Stress, University of Pennsylvania has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Neuromodulation in Depression and Stress, University of Pennsylvania conducted?

Center for Neuromodulation in Depression and Stress, University of Pennsylvania has 1 clinical trials on record. Their work covers Bipolar Depression, Treatment Resistant Depression.

Is Center for Neuromodulation in Depression and Stress, University of Pennsylvania accredited by Crixeo Health?

Center for Neuromodulation in Depression and Stress, University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Neuromodulation in Depression and Stress, University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.